Bosh sahifaSBHMY • OTCMKTS
add
Sino Biopharmaceutical Unsponsored Caymand Islands ADR
Yopilish kursi
7,75 $
Yillik diapazon
6,69 $ - 9,65 $
Bozor kapitalizatsiyasi
53,96 mlrd HKD
Oʻrtacha hajm
58,00
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 7,94 mlrd | 11,14% |
Joriy xarajat | 4,78 mlrd | 10,58% |
Sof foyda | 1,51 mlrd | 139,69% |
Sof foyda marjasi | 19,01 | 115,78% |
Har bir ulushga tushum | — | — |
EBITDA | 1,98 mlrd | 8,88% |
Amaldagi soliq stavkasi | 16,99% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 13,18 mlrd | -15,93% |
Jami aktivlari | 66,70 mlrd | 1,62% |
Jami passivlari | 24,58 mlrd | -15,76% |
Umumiy kapital | 42,12 mlrd | — |
Tarqatilgan aksiyalar | 18,21 mlrd | — |
Narxi/balansdagi bahosi | 4,31 | — |
Aktivlardan daromad | 6,50% | — |
Kapitaldan daromad | 8,37% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 1,51 mlrd | 139,69% |
Operatsiyalardan naqd pul | 1,54 mlrd | 15,25% |
Sarmoyadan naqd pul | -1,02 mlrd | 49,91% |
Moliyadan naqd pul | -2,05 mlrd | -1,42% |
Naqd pulning sof oʻzgarishi | -1,52 mlrd | 43,37% |
Boʻsh pul | 1,09 mlrd | 36,59% |
Haqida
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
CEO
Tashkil etilgan
2000
Sayt
Xodimlar soni
24 437
